Literature DB >> 11036930

Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo.

M G Rosenfeld1, P Briata, J Dasen, A S Gleiberman, C Kioussi, C Lin, S M O'Connell, A Ryan, D P Szeto, M Treier.   

Abstract

During development of the mammalian pituitary gland, specific hormone-producing cell types, critical in maintaining homeostasis, emerge in a spatially and temporally specific fashion from an ectodermal primordium. We have investigated the molecular basis of generating diverse cell phenotypes from a common precursor, providing in vivo and in vitro evidence that development of these cell types involves at least four sequential phases of signaling events and the action of a gradient at an ectodermal boundary. In the first phase, we hypothesize that this notochord induces invagination of Rathke's pouch from the oral ectoderm. This is followed by appearance of an ectodermal boundary, formed with exclusion of Shh from the nascent pouch. Next, signals from the ventral diencephalon--expressing BMP4, Wnt5a, FGF10, and FGF8--in concert with Shh represent critical in vivo signals for pituitary determination. Subsequently, a dorsal-ventral BMP2 signal gradient emanates from a ventral pituitary organizing center, forming at the boundary to oral ectoderm region from which Shh expression is selectively excluded. In concert with a dorsal FGF8 signal, this creates opposing gradients that generate overlapping patterns of specific transcription factors that underlie cell lineage specification events. The mechanisms by which these transient gradients of signaling molecules lead to the appearance of four ventral pituitary cell types appear to involve the reciprocal interactions of two transcription factors, Pit-1 and GATA-2, which are epistatic to the remainder of the cell type-specific transcription programs and serve as a molecular memory of the transient signaling events. Unexpectedly, this program includes a DNA-binding-independent function of Pit-1, suppressing the ventral GATA-2-dependent gonadotrope program by inhibiting GATA-2 binding to gonadotrope- but not thyrotrope-specific genes. This indicates that both DNA-binding-dependent and-independent actions of abundant determining factors contribute to generate distinct cell phenotypes. In the fourth phase, temporally specific loss of the BMP2 signal is required to allow terminal differentiation. The consequence of these sequential organ and cellular determination events is that each of the pituitary cell types--gonadotropes, thyrotropes, somatotropes, lactotropes, corticotropes, and melanotropes appears to be determined, in a ventral to dorsal gradient, respectively, apparently based on a combinatorial code of transcription factors induced by the gradient of specific signaling molecules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036930

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN: 0079-9963


  19 in total

Review 1.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

2.  Thyroid-specific transcription factors control Hex promoter activity.

Authors:  Cinzia Puppin; Angela V D'Elia; Lucia Pellizzari; Diego Russo; Franco Arturi; Ivan Presta; Sebastiano Filetti; Clifford W Bogue; Lee A Denson; Giuseppe Damante
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

3.  GnRH regulation of Jun and Atf3 requires calcium, calcineurin, and NFAT.

Authors:  April K Binder; Jean C Grammer; Maria K Herndon; Julie D Stanton; John H Nilson
Journal:  Mol Endocrinol       Date:  2012-03-22

4.  Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure.

Authors:  Paven K Aujla; Vedran Bogdanovic; George T Naratadam; Lori T Raetzman
Journal:  Dev Dyn       Date:  2015-08       Impact factor: 3.780

5.  Genetic approaches identify adult pituitary stem cells.

Authors:  Anatoli S Gleiberman; Tatyana Michurina; Juan M Encinas; Jose L Roig; Peter Krasnov; Francesca Balordi; Gord Fishell; Michael G Rosenfeld; Grigori Enikolopov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

6.  Prenatal exposure to low doses of bisphenol A increases pituitary proliferation and gonadotroph number in female mice offspring at birth.

Authors:  Katherine E Brannick; Zelieann R Craig; Ashley D Himes; Jackye R Peretz; Wei Wang; Jodi A Flaws; Lori T Raetzman
Journal:  Biol Reprod       Date:  2012-10-11       Impact factor: 4.285

7.  Nkx6.2 synergizes with Cdx-2 in stimulating proglucagon gene expression.

Authors:  Pei-Xiang Wang; Zhi-Wen Yu; Steven Wong; Tian-Ru Jin
Journal:  World J Diabetes       Date:  2011-05-15

Review 8.  Molecular defects in the growth hormone-IGF axis.

Authors:  Joyce Lee; Ram K Menon
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

9.  Structural characterization of the PIT-1/ETS-1 interaction: PIT-1 phosphorylation regulates PIT-1/ETS-1 binding.

Authors:  Kevin D Augustijn; Dawn L Duval; Rainer Wechselberger; Rob Kaptein; Arthur Gutierrez-Hartmann; Peter C van der Vliet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

10.  Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.

Authors:  G Corneli; D Vivenza; F Prodam; G Di Dio; A Vottero; A Rapa; S Bellone; S Bernasconi; G Bona
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.